logo
Select company
Select metric
$ -10.11EBITDA per Share
VS
Market
3
Sector
7
Industry
8
History
94
$ 6.18Close
$ 3 - $ 24 52-Week Range
Ticker Information

Ticker

GBIO

Company Name

GENERATION BIO CO

Sector

Healthcare

Industry

Biotechnology

Exchange

NASDAQ

GENERATION BIO CO - EBITDA per Share Chart Analysis (TTM)

From
Zoom
1Y
3Y
5Y
10Y

GBIO - EBITDAPS Historical data
DateEarnings Before Interest Taxes & Depreciation Amortization (EBITDA)EBITDA per ShareShare FactorWeighted Average Shares
6/30/2025$ -67.79M$ -10.1116.7M
3/31/2025$ -67.17M$ -10.0316.7M
12/31/2024$ -126.74M$ -19.0216.66M
9/30/2024$ -140.39M$ -21.0416.67M
6/30/2024$ -153.23M$ -23.0316.65M
3/31/2024$ -163.81M$ -24.6616.64M
12/31/2023$ -121.35M$ -18.8216.45M
9/30/2023$ -118.55M$ -17.9916.59M
6/30/2023$ -121.52M$ -18.5116.57M
3/31/2023$ -128.47M$ -21.3316.02M
Previous (option currently disabled)
1 (current)
Next (option currently disabled)

Key Performance Insights, Last 5 Years

  • GENERATION BIO CO's latest trailing twelve months (TTM) EBITDAPS stands at $ 0.
  • Over the past 5 years, GENERATION BIO CO's average EBITDAPS has been $ -19.7.
  • The median EBITDAPS for GENERATION BIO CO during this period was $ -20.36
  • GENERATION BIO CO reached its highest EBITDAPS over the past 5 years at $ -10.03.
  • The lowest EBITDAPS recorded by GENERATION BIO CO in the same timeframe $ -28.28

GENERATION BIO CO's EBITDAPS vs. competitors

We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue

EBITDAPS Benchmarks
CompanyEBITDAPS
XLO : XILIO THERAPEUTICS INC $ -0.57BCAB : BIOATLA INC $ -1CRIS : CURIS INC $ -2.97PRPO : PRECIPIO INC $ -0.06MRSN : MERSANA THERAPEUTICS INC $ -13.15DYAI : DYADIC INTERNATIONAL INC $ -0.17XFOR : X4 PHARMACEUTICALS INC $ -11.99NEPH : NEPHROS INC $ 0.14POCI : PRECISION OPTICS CORPORATION INC $ -0.79NRXS : NEURAXIS INC $ -0.82

Definition of EBITDA per Share

[Calculation] The amount of earnings before interest, taxes, depreciation, and amortization attributed to each share, calculated as [EBITDA] divided by the weighted average number of shares [SharesWA] after adjusting for [ShareFactor].
EBITDA / (Shares WA * Share Factor)
(=) EBITDAPS
EBITDAPS for GENERATION BIO CO is calculated as follows: EBITDA [ $ 0 ] / (Shares WA [ 4.55M ] * Share Factor [ 1 ])
(=) EBITDAPS [ $ 0 ]

GBIO - EBITDA per Share, Last 5 years

$ -28.28

Minimum

Dec 31, 2020

$ -10.03

Maximum

Mar 31, 2025

$ -19.7

Average

$ -20.36

Median

EBITDAPS Benchmark Analysis

The chart above depicts the distribution of EBITDAPS for companies in the Total Stock Market. The average EBITDAPS of the companies is $ 2.01 with a standard deviation of $ 4.26.
The following table provides additional summary stats:
EBITDAPS in the Market:
filtered constituents3.78K
min$ -10.86
max$ 13.95
average$ 2.01
median$ 0.99
std$ 4.26